Documentos relacionados

1. Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemia.
2. The effect of hydroxyurea on compound heterozygotes for sickle cell-hemoglobin D-Punjab--a single centre experience in eastern India.
3. Hydroxyurea-induced genital ulcers and erosions: Two case reports.
4. Effectiveness of hydroxycarbamide in children with sickle cell disease - Analysis of dose-response metrics in a large birth cohort in a tertiary sickle cell centre.
5. Enhancing Effect of Hydroxyurea on Hb F in Sickle Cell Disease: Ten-Year Egyptian Experience.
6. Prevalence of Duffy null and its impact on hydroxyurea in young children with sickle cell disease in the United States.
7. Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease.
8. Hydroxyurea use in young infants with sickle cell disease.
9. A randomised controlled provider-blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherence.
10. Individual red blood cell fetal hemoglobin quantification allows to determine protective thresholds in sickle cell disease.